Avian Influenza A Nucleoprotein Ag Capture, 192 Wells
To add this product to your interest list, sign up or login.
Manufacturer: DRG International Inc.
Model: Avian Influenza A Nucleoprotein Ag Capture, 192 wells
Product Code: EIA4711
Purchase the Avian Influenza A Nucleoprotein Ag Capture, 192 wells at a competitive price from Block Scientific, Bellport, New York. We are one of the better known names when it comes to dealing in new and refurbished lab equipment from a wide range of popular manufacturers.
to Recognize Influenza A Antigen
This enzyme immunoassay is a highly sensitive and specific ELISA kit meant for recognizing Influenza A nucleoprotein antigen in complex sample matrices derived from both human and veterinary sources. The test kit incorporates proprietary diluents that are designed to prevent the development of nonspecific signal derived from complex sample matrix effects and/or the nonspecific adsorption of reactive test components which result in improvements in both sensitivity and specificity.
- Can be completed in under 90 minutes
- Only one wash step involved
- Incubation time: 30/45/10 min
- Tested against a wide variety of influenza A subtypes for sensitivity and potentially interfering viruses and bacteria for specificity
About Influenza A Viruses and Infections
A variety of wild waterfowl appear to be the predominant natural reservoir for Influenza A viruses and subtypes representing most of the hemagglutinin and neuraminidase combinations can be found circulating in these birds. Historically, human influenza virus infections have been associated with H1N1, H2N2, and H3N2 subtypes of influenza A, although a recent (1997) and significant outbreak in Hong Kong was identified as an H5N1 subtype. This outbreak was not only significant because it resulted in 18 human infections and 6 deaths, but it also represented the first known demonstration of avian influenza virus transmission to humans. While influenza A subtype identification is extremely important (vaccine production, epidemiology), the rapid and accurate differentiation of influenza A from influenza B and C and other respiratory agents in humans and animals is also
important (treatment and biosecurity).